NYSE:NUS
Nu Skin Enterprises Inc Stock News
$13.65
-0.210 (-1.52%)
At Close: May 17, 2024
Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday
10:06am, Friday, 04'th Nov 2022 Benzinga
U.S. stocks closed lower on Thursday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.
Lincoln National Corporation (NYS
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
08:41am, Friday, 04'th Nov 2022 Benzinga
Gainers
Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.
Acutus
Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session
06:35pm, Thursday, 03'rd Nov 2022 Benzinga
Gainers
Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60.
Virax Biolabs Group Limited (NASDAQ: VRAX) surged 34% to $2.25 after the company announced the distribution of a RSV-I
Nu Skin Enterprises (NUS) Q3 Earnings and Revenues Lag Estimates
10:45pm, Wednesday, 02'nd Nov 2022 Zacks Investment Research
Nu Skin (NUS) delivered earnings and revenue surprises of -39.74% and 5.57%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin Enterprises, Inc. (NUS) Q3 2022 Earnings Call Transcript
09:23pm, Wednesday, 02'nd Nov 2022
Nu Skin Enterprises, Inc. (NYSE:NUS ) Q3 2022 Earnings Conference Call November 2, 2022 5:30 PM ET Company Participants Scott Pond - Vice President of Investor Relations Ryan Napierski - President & C
Nu Skin Enterprises (NUS) Q3 Earnings and Revenues Lag Estimates
08:20pm, Wednesday, 02'nd Nov 2022
Nu Skin (NUS) delivered earnings and revenue surprises of -39.74% and 5.57%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin (NUS) Queued for Q3 Earnings: Things to Consider
04:53pm, Monday, 31'st Oct 2022 Zacks Investment Research
Nu Skin's (NUS) Q3 performance will likely reflect continued economic uncertainty, prolonged COVID-associated factors, unfavorable currency rates and geopolitical conflicts.
Kellogg's (K) Q3 Earnings Upcoming: Here's All You Should Note
03:09pm, Monday, 31'st Oct 2022 Zacks Investment Research
Kellogg's (K) third-quarter 2022 results are likely to reflect gains from the company's revenue growth management actions, whereas cost inflation and supply-chain bottlenecks are likely to have been a
Nu Skin (NUS) Queued for Q3 Earnings: Things to Consider
02:18pm, Monday, 31'st Oct 2022
Nu Skin's (NUS) Q3 performance will likely reflect continued economic uncertainty, prolonged COVID-associated factors, unfavorable currency rates and geopolitical conflicts.
Nu Skin Enterprises (NUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
02:01pm, Wednesday, 26'th Oct 2022 Zacks Investment Research
Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nu Skin's (NUS) Focus on Nu Vision 2025 & Product Launches Aids
02:13pm, Friday, 07'th Oct 2022 Zacks Investment Research
Nu Skin (NUS) is optimistic about its Nu Vision 2025 strategy to become the world's leading integrated beauty and wellness company, driven by a dynamic affiliate opportunity platform.
Infosys (INFY) Rides on Digitization Growth and Collaborations
02:15pm, Tuesday, 04'th Oct 2022 Zacks Investment Research
Infosys (INFY) continues to gain from its high-margin digital business solutions and back-to-back strategic collaboration wins.
Insiders Selling Nasdaq, Bristol-Myers Squibb And This Consumer Defensive Stock
03:05pm, Friday, 23'rd Sep 2022 Benzinga
The Nasdaq Composite dropped by around 150 points on Thursday. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it indicates their concern in the company’s pr
Nu Skin (NUS) Down More Than 15% in 3 Months: Here's Why
02:37pm, Tuesday, 06'th Sep 2022 Zacks Investment Research
Nu Skin (NUS) is battling continued economic uncertainty, prolonged COVID-associated factors, unfavorable currency rates and geopolitical conflicts.
Nu Skin (NUS) Down More Than 15% in 3 Months: Here's Why
12:02pm, Tuesday, 06'th Sep 2022
Nu Skin (NUS) is battling continued economic uncertainty, prolonged COVID-associated factors, unfavorable currency rates and geopolitical conflicts.